Annual Drug Patent Expirations for NOREPINEPHRINE+BITARTRATE+IN+0.9%25+SODIUM+CHLORIDE Norepinephrine Bitartrate In 0.9% Sodium Chloride is a drug marketed by Inforlife and Nevakar Injectables and is included in two NDAs. It is available…
The post New patent for Nevakar Injectables drug NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE appeared first on DrugPatentWatch - Make Better Decisions.